Veterinary Vaccines

Global Veterinary Vaccines Market to Reach US$14.6 Billion by 2030

The global market for Veterinary Vaccines estimated at US$10.5 Billion in the year 2024, is expected to reach US$14.6 Billion by 2030, growing at a CAGR of 5.6% over the analysis period 2024-2030. Porcine Vaccines, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$4.7 Billion by the end of the analysis period. Growth in the Poultry Vaccines segment is estimated at 5.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.8 Billion While China is Forecast to Grow at 5.3% CAGR

The Veterinary Vaccines market in the U.S. is estimated at US$2.8 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.3 Billion by the year 2030 trailing a CAGR of 5.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.2% and 4.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.2% CAGR.

strong>Global Veterinary Vaccines Market - Key Trends and Drivers Summarized

Why Are Veterinary Vaccines Crucial for Animal Health?

Veterinary vaccines are essential tools in safeguarding animal health, preventing the spread of infectious diseases, and promoting overall well-being in livestock, pets, and wildlife. These vaccines work by stimulating the animal`s immune system to recognize and combat specific pathogens, reducing the incidence of diseases such as rabies, distemper, parvovirus, and avian influenza. For livestock, vaccinations are critical in ensuring the health of herds and flocks, thereby protecting food supply chains and minimizing economic losses for farmers. In companion animals, vaccines help maintain the health of pets, preventing potentially deadly diseases and reducing the risk of zoonotic infections that can be transmitted to humans. By controlling disease outbreaks, veterinary vaccines play a vital role in public health, food security, and the humane treatment of animals.

Not Just Animals, How  Veterinary Vaccines Protect Us from Zoonotic Diseases?

Veterinary vaccines play a crucial role in reducing the risk of zoonotic diseases, which are infections transmitted from animals to humans. By immunizing animals, these vaccines prevent the initial establishment and subsequent spread of infectious agents among animal populations, thereby acting as a critical barrier against the transmission to humans. For instance, rabies vaccines administered to wildlife and domestic pets have significantly decreased the incidence of this fatal disease in humans. Similarly, vaccinating livestock against diseases like brucellosis and anthrax, which can be transmitted through direct contact or by consuming contaminated animal products, protects human health and enhances food safety. Furthermore, by controlling these diseases in animal populations, veterinary vaccines reduce the environmental load of pathogens, lowering the chance of human exposure and potential outbreaks. This proactive approach not only safeguards public health but also supports the welfare of domestic and wild animal populations, illustrating the intertwined health of humans and animals within shared ecosystems.

How Are Technological Advances Shaping Veterinary Vaccines?

Technological advancements are revolutionizing the field of veterinary vaccines, making them more effective, safer, and easier to administer. Innovations such as recombinant DNA technology and vector-based vaccines have enabled the development of vaccines that offer broader protection and longer-lasting immunity. For instance, subunit vaccines, which include only parts of the pathogen, reduce the risk of adverse reactions while still providing robust immunity. Additionally, advances in adjuvants—substances that enhance the immune response—are improving the efficacy of vaccines, especially in species that are difficult to immunize. Another significant development is the advent of oral and intranasal vaccines, which simplify administration, particularly in large-scale livestock operations. These innovations are not only enhancing the health and productivity of animals but also ensuring more sustainable and efficient agricultural practices.

What Challenges and Trends Are Impacting the Veterinary Vaccine Industry?

The veterinary vaccine industry faces several challenges, including the constant evolution of pathogens and the need for vaccines that can address multiple strains. The emergence of antibiotic-resistant bacteria underscores the importance of vaccines in reducing reliance on antibiotics, thereby mitigating the risk of resistance. Regulatory hurdles also pose significant challenges, as vaccines must undergo rigorous testing to ensure safety and efficacy, which can be time-consuming and costly. Despite these challenges, there are promising trends shaping the industry. There is a growing emphasis on developing vaccines for emerging diseases, supported by advances in genomics and bioinformatics that allow for rapid identification of pathogen targets. Additionally, the integration of big data and artificial intelligence is streamlining vaccine development processes and improving disease surveillance, enabling more proactive and targeted vaccination strategies.

What Drives the Growth in the Veterinary Vaccines Market?

The growth in the veterinary vaccines market is driven by several factors, including increasing pet ownership and the rising demand for animal-derived food products. As more people consider pets part of their family, there is a greater willingness to invest in preventive healthcare, including vaccinations. In the agricultural sector, the intensification of livestock farming and the need to ensure food safety and security drive the demand for effective vaccines to prevent disease outbreaks. Technological advancements that lead to the development of more effective and convenient vaccines also contribute to market expansion. Moreover, heightened awareness of zoonotic diseases and the role of veterinary vaccines in preventing these infections promote the adoption of vaccination programs. Regulatory support and initiatives to control and eradicate animal diseases further stimulate market growth, ensuring that veterinary vaccines remain a critical component of animal healthcare and public health initiatives.

SCOPE OF STUDY:

The report analyzes the Veterinary Vaccines market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Type (Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines, Other Types); Technology (Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines, Other Vaccines)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 22 Featured) -

• Bayer de México SA de CV
• Biogénesis Bagó SA
• Boehringer Ingelheim International GmbH
• Ceva Santé Animale
• Elanco Animal Health
• Heska Corporation
• Indian Immunologicals Ltd.
• Merck Animal Health
• Virbac SA
• Zoetis Inc.

AI INTEGRATIONS
We`re transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher. Show more